目的观察莫昔沙星序贯治疗社区获得性肺炎(CAP)的安全性和临床疗效。
Objective To survey the safety and clinical therapeutic effectiveness of sequential moxifloxacin administration in the treatment of community acquired pneumonia (CAP).
结论：阿奇霉素联合头孢他啶治疗社区获得性肺炎疗效满意，且无明显不良反应，值得临床推广应用。
Conclusion: Azithromycin combined with Ceftazidime in the treatment of community acquired pneumonia has satisfactory curative effect and no significant adverse reaction, it is worth spreading.
结论阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎优于上述单种抗生素。
Conclusion There is a better efficacy of combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia than azithromycin or ceftriaxone sodium used individually.
结论阿奇霉素联合头孢曲松钠治疗重症社区获得性肺炎优于上述单种抗生素。
Conclusion There is a better efficacy of combining azithromycin with ceftriaxone sodium for treating severity community acquired pneumonia than azithromycin or ceftriaxone sodium used individually.
应用推荐